Drug intelligence / Profile preview

nitrazepam

Development stage
Phase 4
Lead developer
Roche
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Nitrazepam is a long-acting benzodiazepine used primarily for the short-term treatment of insomnia and the management of certain types of seizures such as myoclonic seizures. It acts as a powerful hypnotic with strong sedative properties and also exhibits anxiolytic (anti-anxiety), amnestic (impairing memory), anticonvulsant (preventing seizures), and skeletal muscle relaxant effects. The drug works by binding to central benzodiazepine receptors that are associated with gamma-aminobutyric acid type A (GABA-A) receptors in the brain. This enhances GABA's inhibitory effect on neuronal activity leading to sedation and CNS depression. Additionally—especially at higher doses or in specific contexts—nitrazepam may exert anticonvulsant effects through interaction with voltage-dependent sodium channels by slowing their recovery from inactivation. It is metabolized hepatically and has a risk for abuse and dependence. Developed by Roche.

Brand names
MogadonAlodormaMogadonaNit-10Nit10Nit 10NitNiavetEnzedNitravetBaroniteNitrosunSleeparm 10Sleeparm10Sleeparm-10SleeparmNitrosymNite 10 mgNite10 mgNite-10 mgNiteNitraz-SR 10 mgNitraz-SR10 mgNitraz-SR-10 mgNitraz-SRNitzy-10Nitzy10Nitzy 10
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)BZD site (GABA-A receptor benzodiazepine site)GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)

Beyond the preview

Go deeper on nitrazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitrazepam.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call